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Abstract
Within epidemiological modeling, the majority of
analyses assume a single epidemic process for gen-
erating ground-truth data. However, this assumed
data generation process can be unrealistic, since
data sources for epidemics are often aggregated
across geographic regions and communities. As
a result, state-of-the-art models for estimating epi-
demiological parameters, e.g. transmission rates,
can be inappropriate when faced with complex sys-
tems. Our work empirically demonstrates some
limitations of applying epidemiological models to
aggregated datasets. We generate three complex
outbreak scenarios by combining incidence curves
from multiple epidemics that are independently
simulated via SEIR models with different sets of
parameters. Using these scenarios, we assess the
robustness of a state-of-the-art Bayesian inference
method that estimates the epidemic trajectory from
viral load surveillance data. We evaluate two data-
generating models within this Bayesian inference
framework: a simple exponential growth model
and a highly flexible Gaussian process prior model.
Our results show that both models generate accu-
rate transmission rate estimates for the combined
incidence curve at the cost of generating biased
estimates for each underlying epidemic, reflecting
highly heterogeneous underlying population dy-
namics. The exponential growth model, while in-
terpretable, is unable to capture the complexity of
the underlying epidemics. With sufficient surveil-
lance data, the Gaussian process prior model cap-
tures the shape of complex trajectories, but is im-
precise for periods of low data coverage. Thus, our
results highlight the potential pitfalls of neglecting
complexity and heterogeneity in the data genera-
tion process, which can mask underlying location-
and population-specific epidemic dynamics.
∗Equal contribution
Our Python implementation of the Bayesian inference method
using viral load surveillance data is open source and available at
https://github.com/pargaw/pyCt
1 Introduction
Reliable testing and reporting of new cases play key roles in
early detection and management of an epidemic. For exam-
ple, testing data are often used to generate predictions regard-
ing the dynamics of an epidemic [Tolles and Luong, 2020]
to guide interventions enforced by governments [Brauner et
al., 2021]. Data sources for epidemics are usually aggre-
gated across geographic regions and spatial scales [Dong et
al., 2020]. However, aggregating datasets can mask spatial
heterogeneity in underlying incidence trends [Chang et al.,
2021]. In fact, it has been shown that individual-level data can
better inform risk models’ predictions [Xu et al., 2020], es-
pecially for disadvantaged communities [Chang et al., 2021].
Still, due to limited access to data (e.g. during early de-
tection stages), epidemiologists must simulate epidemics to
generate scenarios or predictions for possible outcomes of in-
terventions [Tolles and Luong, 2020]. Because of the com-
plexities in disease and population dynamics, routinely used
epidemiological models (e.g. compartmental models) make
assumptions that can be oversimplifying [Tolles and Luong,
2020].
For the scope of this work, we adopt the recent Ct model to
evaluate our simulated complex outbreak scenarios. The Ct
model estimates epidemiological dynamics from viral load
distributions, namely cycle threshold (Ct) values from real-
time PCR assays [Hay et al., 2021]. Ct values represent
the viral load in a person at a given point in time, and the
distribution of detectable viral loads under random cross-
sectional surveillance has been shown to be informative of
the epidemic growth rate [Hay et al., 2021]. Specifically,
low Ct values (Ct ≤ 29) correspond to high viral loads ob-
served, indicating recent epidemic growth, while high Ct val-
ues (38 ≤ Ct ≤ 40; Ct values above 40 cannot be measured
due to technical limitations of real-time PCR assays) corre-
spond to low viral loads observed, indicating recent epidemic
decline [Hay et al., 2021]. Still, the Ct model, like other state-
of-the-art (SoTA) models for estimating epidemiological dy-
namics, assumes a single epidemic process that generates the
data. We use the Ct model as a demonstration—any epidemi-
ological model can be applied instead—to evaluate an epi-
demiological model’s robustness in differentiating complex
population structures and epidemiological dynamics.
Our evaluation process comprises of two main compo-
nents: simulating three scenarios in which two distinct
populations—with different susceptibility, infectious, incu-
bation, and recovery rates—interact (Sections 2 and 3); and
measuring the fit of the Ct model on the combined popula-
tions’ viral load distributions (Sections 2 and 4). We also
empirically demonstrate the model’s sensitivity to the choice
of a posterior sampling method (Section 4).
Ultimately, our results highlight some of the challenges in
implementing and deploying epidemiological models. While
it is clearly naive to assume a single data-generating pro-
cess for a dataset constructed by two underlying epidemic
processes, we hypothesize that estimates from an epidemi-
ological model can only reflect one of the epidemics and/or
populations, depending on the stage of the two underlying
epidemics and how well the data represent the two popula-
tions. For example, suppose we have an abundance of surveil-
lance data from population #1 that indicate an epidemic de-
cline, and sparse surveillance data from population #2, which
is entering an epidemic growth phase. After combining the
datasets, we must be careful not to incorrectly conclude that
population #2 is also in the decline phase of the epidemic.
Blindly aggregating data can lead to flawed policy decisions.
Thus, as shown through this work, our recommendation is
to evaluate the level of aggregation in the data before draw-
ing conclusions (e.g. Given only state-aggregated data, how
well-equipped are we to make county-level decisions?).
2 Methods
We begin with an overview of the models used to simulate
and evaluate the outbreak scenarios described in Section 3.
We utilize these simulated data to assess the accuracy of the
inference approach in estimating the true epidemic trajectory.
We note that our simulation settings are set to broadly reflect
a SARS-CoV-2 outbreak, but our findings can be considered
pathogen-nonspecific.
2.1 Simulations via SEIR model
We simulate our complex scenarios with a compartmen-
tal model, specifically the Susceptible-Exposed-Infectious-
Recovered (SEIR) model. We use a basic SEIR model [Ma,
2020], where the population size N = S + E + I + R, and







= βSI − σE (2)
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where β is the transmission rate (or rate in which susceptible
individuals get exposed), σ is the incubation rate (or rate at
which exposed individuals become infectious), and γ is the
recovery rate (or rate at which infectious individuals recover).
2.2 Simulations via Ct model
After generating epidemic incidence curves for each of the
scenarios using the SEIR model, we simulate observable Ct
Table 1: Default parameters for the simulated scenarios. We set










Table 2: Scaling factors for the simulated outbreak scenarios.
For our simulations, we define scaling factors for the SEIR model
parameters N , R0, and γ, where R0 = β/γ. We only report the
scaling factors for population #1 because the parameters are scaled
relative to population #2, whose parameters are scaled by 1.
Scenario N R0 γ
Out-of-state travel (Section 3.2) 1 2 1.5
Seasonal travel (Section 3.3) 0.5 0.8 0.8
NPIs (Section 3.4) 1 0.8 1
values under random cross-sectional surveillance, assuming
that infected individuals are tested at an unknown point in
their infection. The frequency and number of tests simulated
are specified in Table S1. To capture the fact that measured
Ct values depend on the age of an infection, a, we use a pre-
viously described model for modal viral load (or Ct) kinetics,
Cmode(a), assuming that observed Ct values follow a Gumbel
distribution [Hay et al., 2021]
C(a) ∼ Gumbel(Cmode(a), σ(a)) (5)
where σ(a) captures the observation that the Ct values ex-
hibit less variability in older infections. We also assume that
the parameters underlying the Ct model are known precisely
based on previous estimates [Hay et al., 2021].
2.3 Single Cross-Section Model
We infer epidemic growth rates by fitting an exponential
growth model given a single cross-section of observed Ct val-
ues. Briefly, the aim is to infer the recent growth rate of the
epidemic using the distribution of Ct values obtained at a sin-
gle point in time. An exponential growth model is simple yet
interpretable because it has only one free parameter, which
denotes the direction and magnitude of the epidemic trajec-
tory from a single cross-section of data. We assume that the
daily incidence over the Amax days before the testing day t
grows or declines exponentially with rate β such that
πt−a = π0e
β(t−a) (6)
where β is the logarithm of the daily growth rate in incidence
over the days t−Amax and t− 1, π0 is a nuisance parameter
that can be ignored, and we assume a prior β ∼ N (0, 0.25).
2.4 Multiple Cross-Section Model
We also infer epidemic growth rates by fitting a Gaussian pro-
cess model given multiple cross-sections. Gaussian Processes
(GPs) [Rasmussen, 2003] are a powerful non-parametric
framework for performing Bayesian inference. The frame-
work pairs a GP prior on daily incidence rate [Xu et al., 2016]
with a custom Ct likelihood function. The flexibility of the
GP prior allows for practitioners to analyze multiple test days,
as the priors do not assume specific parameters. Our choices
of a covariance function and hyperparameters are manually
specified by domain experts. [Hay et al., 2021] uses a modi-
fied version of the squared exponential (SE) kernel:





with hyperparameters η = 1.5, ρ = 0.03. Therefore, daily
incidence is defined as
πt−a = (1 + exp(−f))−1 (8)
where f ∼ N (0,K) and K is a covariance matrix generated
by k. For sampling, we use Hamilton Monte Carlo [Duane
et al., 1987] with a No-U-Turn sampler [Hoffman and Gel-
man, 2014] because it is a more efficient MCMC method than
Metropolis-Hastings [Robert and Casella, 1999], the sampler
used in the implementation by [Hay et al., 2021].
3 Simulated Scenarios
We next introduce our scenarios for evaluating the robustness
of the Ct model. We create the scenarios by independently
simulating outbreaks in two populations, and then combining
their simulated Ct values observed through surveillance test-
ing (Figure S1). In each scenario, we arbitrarily define scal-
ing factors for SEIR model parameters (Table 2) to generate
outbreaks with different transmission dynamics (Figure 1).
The choices of parameters and scaling factors are designed
to qualitatively demonstrate the desired epidemiological dy-
namics within the following scenarios, and we note that other
parameter choices may give different dynamics but qualita-
tively similar results.
3.1 Baseline
As a baseline, we simulate a simple scenario with only one
population using the default parameters in Tables 1 and S1.
3.2 Out-of-State Travel
We simulate a scenario in which population #1 consists of
younger individuals (e.g. college students) who travel into a
community (population #2) from out-of-state (e.g. for spring
break). We assume that the rate of recovery (γ) in the incom-
ing younger individuals is higher on average than that of the
community, broadly reflecting the epidemiological situation
for SARS-CoV-2, where younger individuals are less likely
to experience symptomatic infections [Davies et al., 2020].
We also assume that the potential for transmission (R0) is
higher in population #1 to reflect higher numbers and inten-
sity of contacts amongst younger individuals. Further, the Ct
model is built to incorporate variation across a population, in-
cluding in age structures [Hay et al., 2021]. Here, we assume
that individuals in the two populations follow the same viral
kinetics model (Table S1), and only vary the SEIR model pa-
rameters in Table 2. We combine the populations by adding
their Ct values at corresponding times t ∈ [0, 250] (Figure 1).
3.3 Seasonal Travel
We simulate the dynamics of an epidemic in a community
(e.g. college town) as a result of seasonal travel (e.g. stu-
dents in town for the semester or leaving during the breaks).
Population #1 consists of individuals found in the town dur-
ing the breaks; population #2 consists of those present during
the semester. In this scenario, the effect of population den-
sity can be modeled using a density-dependent compartment
model (Table 2). The transmission rate is defined as β = pC,
where p is the probability of infection per contact, and C is
the number of contacts per unit time. We assume that popu-
lation #1 has a lower transmission potential since the number
of contacts per unit time decreases (R0 is scaled by 0.8). As
the younger population leaves the town, population size and
recovery rate also decrease. We combine the two populations
by specifying the outbreaks in populations #1 and #2 to occur
at t ∈ [0, 250] and t ∈ [251, 500], respectively (Figure 1).
3.4 Non-Pharmaceutical Interventions
We simulate a scenario in which non-pharmaceutical inter-
ventions (NPIs) (e.g. curfews, mask mandates) are enforced
in one population (population #1) but not in another (popu-
lation #2). We assume that the enforcement of NPIs results
in a lower transmission rate (R0) (Table 2). We combine the
populations as described in Section 3.2 (Figure 1).
4 Results
The exponential growth and GP prior models output average
growth rates for a set of 8 defined time points (or 16 in the
seasonal travel scenario by the exponential growth model). At
each time point t, we show the predicted growth rate (namely,
β for the exponential model and f for the GP prior model) and
the true growth rate derived from the true incidence values.
To evaluate the robustness of the two models, we compare the
predicted growth rates against the true growth rates within a
95% credible interval. Predictions are generated using only
observed Ct values as input data (i.e. Ct < 40), so only data
from infected individuals are included in the inference. Thus,
estimates for the epidemic trajectory give relative, rather than
absolute, incidence rates since we do not include information
on the proportion of individuals who are infected.
4.1 Baseline
We first compare both methods’ performance on a single stan-
dard incidence rate trajectory generated from a SEIR model
(Section 3.1). Both models are able to estimate the correct di-
rection of the epidemic, and the GP prior model can even cap-
ture the full shape of the trajectory as we increase the number
of cross-sections (Figures 2a and 3a). However, despite the
simple trajectory, the exponential growth model has difficulty
predicting growth rates near the inflection point of the curve
(Figure S2), and the GP prior model needs—in our case—at
least two cross-sections to capture the shape (Figure 4).
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Figure 1: Incidence rates across individual and aggregated populations for each outbreak scenario. (a) The baseline scenario consists
of only one population (Section 3.1), whose incidence rates are shown in blue. Each of the (b) out-of-state travel (Section 3.2), (c) seasonal
travel (Section 3.3), and (d) NPIs (Section 3.4) scenarios has two panels: on the left are two incidence rate curves from populations #1 (blue)
and #2 (green); and on the right is the incidence rate curve of the aggregated dataset. The red dots indicate times when testing is performed.
4.2 Out-of-State Travel
In the out-of-state travel scenario, our exponential model is
able to fit the combined incidence curve within all testing
times except for when there is high variability across the
two populations (namely, t ∈ {55, 69}) (Figure S3). This is
due to the fact that the aggregated dataset’s incidence rate is
the mean of the two populations’ incidence rates (Figure 1a).
Since the rate of decrease in population #1 is greater than the
rate of increase in population #2 at t ∈ {55, 69}, the predicted
growth rate shows a sharper decline than the true growth rate
(Figures 2b and S3). Interestingly, the mean predicted growth
rate for t = 83 is approximately two times greater than the
true growth rate, although it is still within the 95% credible
interval (Figure 2b).
The GP prior model is able to fully capture the shape of the
trajectory of population #2, but not that of the trajectory of
population #1 (Figure 3b). The peak of population #1’s epi-
demic occurs before the first testing time point (Figure 1b), so
the GP prior model is only able to infer the epidemic decline
in population #1 (Figure 3b). As a result of this limitation
in surveillance data, even the GP prior model cannot accu-
rately fit the initial incidence curve of population #1 despite
its overconfident uncertainty intervals (Figure 3b).
4.3 Seasonal Travel
As there is no overlap between the two populations in the sea-
sonal travel scenario (Figure 1b), there is very little variability
in the aggregated dataset. Thus, the exponential model seems
to be robust in most of the sampled times (Figures 2c and S4).
The GP prior model is able to capture the full trajectory, in-
cluding both peaks, as well because their testing time points
are densely scattered (Figure 3c). We also note that the GP
prior model is able to handle the aleatoric uncertainty well,
as shown by the large uncertainty intervals between times
t ∈ [175, 250], when no surveillance data is available.
4.4 Non-Pharmaceutical Interventions
The exponential model performs slightly better in the NPIs
scenario than in the out-of-state travel scenario (Figures 2d
and S5). Although the populations have opposing trajectories
at t ∈ {97, 111}, the fit of the exponential model falls within
our 95% credible boundary across all time points.
The GP prior model is also able to capture the full trajec-
tory when given enough cross-sections (Figure 3d). Similarly
with our baseline experiment, the GP prior model struggles
when there are too few testing time points (i.e. t < 50). How-
ever, it is important to note that the GP prior model captures
a fair amount of uncertainty for the first cross-section.
5 Conclusion
In this work, we demonstrate the limitations of SoTA epi-
demiological models in capturing the heterogeneity in un-
derlying aggregated datasets’ population structures and epi-
demiological dynamics. While both the exponential growth
and GP prior models are able to infer the direction of the
combined epidemic across most time points, the models’ es-
timated trajectories tend to reflect the population and/or epi-
demic with the highest abundance in surveillance data (e.g. in
the out-of-state travel scenario). Although the exponential
growth model seems to accurately estimate simple epidemic
trajectories with limited data at time points far from inflection
points (e.g. in the baseline and seasonal travel scenarios), it
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Figure 2: Evaluation of the exponential growth model for each outbreak scenario. For the (a) baseline, (b) out-of-state travel, (c) seasonal
travel, and (d) NPIs scenarios, we show the predicted growth rates (average taken between t − 35 and t) and the 95% credible interval for
the 8 time points t (dot and vertical line), and their corresponding true growth rates (gray curve). Note that the true growth rates exhibit high







































Figure 3: Evaluation of the Gaussian process prior model for each outbreak scenario. For the (a) baseline, (b) out-of-state travel,










Baseline: Growth Rates at Various Cross Sections
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Figure 4: Limitations of the Gaussian process prior model. We use the baseline scenario to demonstrate the limitations of the GP prior
model. As the number of cross-sections increase (the leftmost panel shows one cross-section; the rightmost panel, four), the GP prior model’s
ability to capture the trajectory of the epidemic improves.
fails to capture the complexities of two conflicting trajectories
(e.g. in the out-of-state travel scenario). On the other hand,
the highly flexible GP prior model can only accurately fit ag-
gregated trajectories when provided sufficient cross-sections
that are densely scattered (e.g. unlike in the seasonal travel
scenario).
Future work regarding the epidemiological models in-
cludes exploring the effects of model selection (e.g. kernels k,
hyperparameters η and ρ) for the GP prior model in order to
address its limitations in estimating aggregated datasets. Our
Python implementation of the Ct, exponential growth, and
Gaussian process prior models are open source and available.
Given the potentially high-impact repercussions of biased and
inaccurate models (e.g. when being used to advise govern-
ment interventions), we must explore strategies for data ag-
gregations such that models are both robust and fair towards
heterogeneous population structures and epidemic dynamics.
Moreover, epidemiological models’ performance could pos-
sibly provide insights on the allocation of testing resources to
ensure that adequate data is obtained for fitting the models.
6 Broader Impact Statement
Our work is primarily motivated by the need to account
for spatial heterogeneity when estimating epidemiological
parameters. This is particularly important due to the use
of epidemiological models to inform public health policies
(e.g. travel restrictions, mask-wearing) [Brauner et al., 2021].
Some potential implications of an inaccurate model include
(1) inadvertently forcing the population to stay longer than
necessary in quarantine or lockdown, which could negatively
affect the economy, overall psychological health, and inter-
personal relationships; or (2) releasing interventions when
incidence is still at the early stage of growth. Nevertheless,
our models are unable to make direct recommendations; we
are simply highlighting the discrepancies of epidemiological
models.
As our results are drawn directly from simulated data, we
must consider the advantages and disadvantages of generat-
ing our own data rather than using real-world data. One ma-
jor advantage is that it enables us to preserve the privacy of
individuals [El Emam et al., 2021]. Moreover, because it
is relatively straightforward to manipulate the parameters of
compartmental models (e.g. SEIR model), we can simulate
a wide range of desired scenarios for investigation. While
many studies have validated synthetic data as adequate prox-
ies for real-world data [El Emam et al., 2021], there may still
be artificial biases introduced by the simulations.
Finally, our criticism of epidemiological models should be
considered in the context of current state-of-the-art models’
capabilities. Although standard models often make oversim-
plifying assumptions, it is important to recognize that model-
ing real world dynamics is highly complex and challenging.
The ability to capture even some of the key contributing fac-
tors of an epidemic using a simple model is valuable, as it can
enable further extrapolation to more robust models.
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Mrinank Sharma, David Johnston, John Salvatier, Tomáš
Gavenčiak, Anna B Stephenson, Gavin Leech, George Alt-
man, Vladimir Mikulik, et al. Inferring the effectiveness of
government interventions against covid-19. Science, 2021.
[Chang et al., 2021] Serina Chang, Emma Pierson, Pang Wei
Koh, Jaline Gerardin, Beth Redbird, David Grusky, and
Jure Leskovec. Mobility network models of covid-19 ex-
plain inequities and inform reopening. Nature, 2021.
[Davies et al., 2020] Nicholas G Davies, Petra Klepac, Yang
Liu, Kiesha Prem, Mark Jit, and Rosalind M Eggo. Age-
dependent effects in the transmission and control of covid-
19 epidemics. Nature Medicine, 2020.
[Dong et al., 2020] Ensheng Dong, Hongru Du, and Lauren
Gardner. An interactive web-based dashboard to track
covid-19 in real time. The Lancet Infectious Diseases,
2020.
[Duane et al., 1987] Simon Duane, Anthony D Kennedy,
Brian J Pendleton, and Duncan Roweth. Hybrid monte
carlo. Physics Letters B, 1987.
[El Emam et al., 2021] Khaled El Emam, Lucy Mosquera,
Elizabeth Jonker, and Harpreet Sood. Evaluating the util-
ity of synthetic covid-19 case data. JAMIA Open, 2021.
[Hay et al., 2021] James A. Hay, Lee Kennedy-Shaffer, San-
jat Kanjilal, Niall J. Lennon, Stacey B. Gabriel, Marc Lip-
sitch, and Michael J. Mina. Estimating epidemiologic dy-
namics from cross-sectional viral load distributions. Sci-
ence, 2021.
[Hoffman and Gelman, 2014] Matthew D Hoffman and An-
drew Gelman. The no-u-turn sampler: adaptively setting
path lengths in hamiltonian monte carlo. JMLR, 2014.
[Ma, 2020] Junling Ma. Estimating epidemic exponential
growth rate and basic reproduction number. Infectious Dis-
ease Modelling, 2020.
[Rasmussen, 2003] Carl Edward Rasmussen. Gaussian pro-
cesses in machine learning. In Summer School on Machine
Learning, 2003.
[Robert and Casella, 1999] Christian P Robert and George
Casella. The metropolis—hastings algorithm. In Monte
Carlo Statistical Methods. 1999.
[Tolles and Luong, 2020] Juliana Tolles and ThaiBinh Lu-
ong. Modeling epidemics with compartmental models.
JAMA, 2020.
[Xu et al., 2016] Xiaoguang Xu, Theodore Kypraios, and
Philip D O’Neill. Bayesian non-parametric inference for
stochastic epidemic models using gaussian processes. Bio-
statistics, 2016.
[Xu et al., 2020] Bo Xu, Bernardo Gutierrez, Sumiko
Mekaru, Kara Sewalk, Lauren Goodwin, Alyssa Loskill,
Emily L Cohn, Yulin Hswen, Sarah C Hill, Maria M Cobo,
et al. Epidemiological data from the covid-19 outbreak,
real-time case information. Scientific Data, 2020.
Appendix A Inference Models
The inference models from [Hay et al., 2021] can be decomposed into two components: (1) a custom Ct likelihood and (2) a
prior on the growth rate parameter(s). The custom likelihood for a single-cross section at time t is as follows:












where, for testing day t, πt−a := probability that a randomly-selected individual in the population was infected on day t − a,
pa(x) := probability that Ct value is x for a test conducted a days after infection, and φa := probability of a Ct value being
detectable a days after infection. Since we only consider detectable Ct values for a cross-section, the likelihood simplifies into:









where n is the number of detectable Ct values in the cross-section. Since the likelihood can lead to overflow values, we use
log-likelihood. Using the log-likelihood does not disrupt the optimization problem because log is monotonic.











A.1 Single Cross-Section Model
The single-cross section model assigns a normal prior on a single growth rate parameter β ∼ N (0, 0.25). We assume a fixed
growth rate for Amax = 35 days. Daily incidence within that interval is πt−a = exp(β(t − a)). With both components, we
obtain a posterior distribution:
p(β|X1, ..., Xn) ∝ l(X1, ..., Xn|β)p(β)
We sample from the posterior and obtain draws of β. We then use these β’s to construct a posterior predictive, which we
compare against the true incidence rates. Note that when we compare against incidence rates, we need to modify the likelihood
function such that π = [πt−a/
∑Amax
a=1 πt−a] reflects an incidence rate.
A.2 Multiple Cross-Section Model
For the multiple cross section model, we leverage the function space view of Gaussian process priors [Rasmussen, 2003].
Instead of sampling a parameter, we directly sample functions that represent the incidence rate curve. A GP prior is defined
entirely by its kernel function, which are usually specified directly by domain experts. Accounting for multiple cross sections
is a natural extension from the single cross section model and is given by:
L(Xt11 , ..., Xt1n1 , ..., X
tT
1 , ..., X
tT














The log likelihood is derived below:
logL(Xt11 , ..., Xt1n1 , ..., X
tT
1 , ..., X
tT
















Again, we need to modify the likelihood function to replace π = [πt−a/
∑Amax
a=1 πt−a] such that it generates incidence rates.
Appendix B Supplementary Tables
Table S1: Testing times and counts from Ct simulations. We present the number of Ct values collected at each testing time for all scenarios.
Scenario t = 55 t = 69 t = 83 t = 97 t = 111 t = 125 t = 139 t = 153
Baseline 49 172 466 777 612 342 140 50
Out-of-state travel 1148 466 523 710 616 334 140 61
Seasonal travel 6 9 27 71 120 240 402 463
NPIs 52 221 553 883 959 787 573 390
t = 305 t = 319 t = 333 t = 347 t = 361 t = 375 t = 389 t = 403
Seasonal travel 36 149 412 737 619 328 142 50














































Ct Values for NPIs
Figure S1: Ct values of simulated data. For the (a) baseline, (b) out-of-state travel, (c) seasonal travel, and (d) NPIs scenarios, we show the
distribution of Ct values across the combined populations at each observed time point.




































































































Figure S2: Evaluation of the exponential growth model on the baseline scenario. For each of the 8 time points, we show the predicted
growth rates β from the exponential growth model (blue) and the true incidence rate (black). The value for β shown in each figure legend is
the posterior mean estimate. The model is able to estimate the correct direction of the epidemic; however, despite the simple trajectory, it has
difficulty predicting growth rates near the inflection point of the curve.

































































































Figure S3: Evaluation of the exponential growth model on the out-of-state travel scenario. For each of the 8 time points, we show the
predicted growth rates β from the exponential growth model (blue) and the true incidence rate (black). The value for β shown in each figure
legend is the posterior mean estimate. The model is able to correctly fit the combined incidence curve within all testing times except at
t ∈ {55, 69, 111}, of which t ∈ {55, 69} are locations of high variability across the populations, and t = 111 is an inflection point.
































































































































































































Figure S4: Evaluation of the exponential growth model on the seasonal travel scenario. For each of the 16 time points, we show the
predicted growth rates β from the exponential growth model (blue) and the true incidence rate (black). The value for β shown in each figure
legend is the posterior mean estimate. As there is no overlap between the two populations in this scenario, we observe very little variability
in the aggregated dataset. The exponential growth model is robust in all sampled times except at t = 361, the inflection point of the curve.






























































































Figure S5: Evaluation of the exponential growth model on the NPIs scenario. For each of the 8 time points, we show the predicted
growth rates β from the exponential growth model (blue) and the true incidence rate (black). The value for β shown in each figure legend
is the posterior mean estimate. The model performs relatively well in this scenario. Although the populations have opposing trajectories at
t ∈ {97, 111}, the fit of the exponential model falls within the 95% credible interval across all time points.
